Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Molnupiravir Market
4. Executive Summary
5. Voice of Customer
5.1. Factors Contributing to Demand of Molnupiravir
5.2. Choice of Source for Procuring Molnupiravir
5.3. Source of Information
5.4. Barriers to Adoption of Molnupiravir
5.5. Brand Awareness
6. Pharmacodynamic Overview of Molnupiravir
6.1. Mechanism of Action
6.2. Absorption
6.3. Volume of Distribution
6.4. Protein Binding
6.5. Metabolism
6.6. Route of Elimination
6.7. Half Life
6.8. Clearance
7. Clinical Trials
7.1. Ongoing Clinical Trials
7.2. Completed Clinical Trials
7.3. Terminated Clinical Trials
7.4. Clinical Trial Analysis
8. Patent Analysis
8.1. Patent Granted (2017-2021)
8.2. Patent Applications Filed
9. Global Molnupiravir Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Application (Influenza, Ebola, COVID-19, Others)
9.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
9.2.3. By Company (2021)
9.2.4. By Region
9.3. Pricing Analysis
9.4. Product Market Map
10. North America Molnupiravir Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Distribution Channel
10.2.3. By Country
10.3. Pricing Analysis
10.4. North America: Country Analysis
10.4.1. United States Molnupiravir Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value & Volume
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Application
10.4.1.2.2. By Distribution Channel
10.4.2. Mexico Molnupiravir Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value & Volume
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Application
10.4.2.2.2. By Distribution Channel
10.4.3. Canada Molnupiravir Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value & Volume
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Application
10.4.3.2.2. By Distribution Channel
11. Europe Molnupiravir Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By Distribution Channel
11.2.3. By Country
11.3. Pricing Analysis
11.4. Europe: Country Analysis
11.4.1. France Molnupiravir Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value & Volume
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Application
11.4.1.2.2. By Distribution Channel
11.4.2. Germany Molnupiravir Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value & Volume
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Application
11.4.2.2.2. By Distribution Channel
11.4.3. United Kingdom Molnupiravir Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value & Volume
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Application
11.4.3.2.2. By Distribution Channel
11.4.4. Italy Molnupiravir Market Outlook
11.4.4.1. Market Size & Forecast
11.4.4.1.1. By Value & Volume
11.4.4.2. Market Share & Forecast
11.4.4.2.1. By Application
11.4.4.2.2. By Distribution Channel
11.4.5. Spain Molnupiravir Market Outlook
11.4.5.1. Market Size & Forecast
11.4.5.1.1. By Value & Volume
11.4.5.2. Market Share & Forecast
11.4.5.2.1. By Application
11.4.5.2.2. By Distribution Channel
11.4.6. Denmark Molnupiravir Market Outlook
11.4.6.1. Market Size & Forecast
11.4.6.1.1. By Value & Volume
11.4.6.2. Market Share & Forecast
11.4.6.2.1. By Application
11.4.6.2.2. By Distribution Channel
12. Asia-Pacific Molnupiravir Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value & Volume
12.2. Market Share & Forecast
12.2.1. By Application
12.2.2. By Distribution Channel
12.2.3. By Country
12.3. Pricing Analysis
12.4. Asia-Pacific: Country Analysis
12.4.1. China Molnupiravir Market Outlook
12.4.1.1. Market Size & Forecast
12.4.1.1.1. By Value & Volume
12.4.1.2. Market Share & Forecast
12.4.1.2.1. By Application
12.4.1.2.2. By Distribution Channel
12.4.2. India Molnupiravir Market Outlook
12.4.2.1. Market Size & Forecast
12.4.2.1.1. By Value & Volume
12.4.2.2. Market Share & Forecast
12.4.2.2.1. By Application
12.4.2.2.2. By Distribution Channel
12.4.3. South Korea Molnupiravir Market Outlook
12.4.3.1. Market Size & Forecast
12.4.3.1.1. By Value & Volume
12.4.3.2. Market Share & Forecast
12.4.3.2.1. By Application
12.4.3.2.2. By Distribution Channel
12.4.4. Japan Molnupiravir Market Outlook
12.4.4.1. Market Size & Forecast
12.4.4.1.1. By Value & Volume
12.4.4.2. Market Share & Forecast
12.4.4.2.1. By Application
12.4.4.2.2. By Distribution Channel
12.4.5. Australia Molnupiravir Market Outlook
12.4.5.1. Market Size & Forecast
12.4.5.1.1. By Value & Volume
12.4.5.2. Market Share & Forecast
12.4.5.2.1. By Application
12.4.5.2.2. By Distribution Channel
12.4.6. Vietnam Molnupiravir Market Outlook
12.4.6.1. Market Size & Forecast
12.4.6.1.1. By Value & Volume
12.4.6.2. Market Share & Forecast
12.4.6.2.1. By Application
12.4.6.2.2. By Distribution Channel
12.4.7. Philippines Molnupiravir Market Outlook
12.4.7.1. Market Size & Forecast
12.4.7.1.1. By Value & Volume
12.4.7.2. Market Share & Forecast
12.4.7.2.1. By Application
12.4.7.2.2. By Distribution Channel
12.4.8. Indonesia Molnupiravir Market Outlook
12.4.8.1. Market Size & Forecast
12.4.8.1.1. By Value & Volume
12.4.8.2. Market Share & Forecast
12.4.8.2.1. By Application
12.4.8.2.2. By Distribution Channel
12.4.9. Malaysia Molnupiravir Market Outlook
12.4.9.1. Market Size & Forecast
12.4.9.1.1. By Value & Volume
12.4.9.2. Market Share & Forecast
12.4.9.2.1. By Application
12.4.9.2.2. By Distribution Channel
13. South America Molnupiravir Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value & Volume
13.2. Market Share & Forecast
13.2.1. By Application
13.2.2. By Distribution Channel
13.2.3. By Country
13.3. Pricing Analysis
13.4. South America: Country Analysis
13.4.1. Brazil Molnupiravir Market Outlook
13.4.1.1. Market Size & Forecast
13.4.1.1.1. By Value & Volume
13.4.1.2. Market Share & Forecast
13.4.1.2.1. By Application
13.4.1.2.2. By Distribution Channel
13.4.2. Argentina Molnupiravir Market Outlook
13.4.2.1. Market Size & Forecast
13.4.2.1.1. By Value & Volume
13.4.2.2. Market Share & Forecast
13.4.2.2.1. By Application
13.4.2.2.2. By Distribution Channel
13.4.3. Colombia Molnupiravir Market Outlook
13.4.3.1. Market Size & Forecast
13.4.3.1.1. By Value & Volume
13.4.3.2. Market Share & Forecast
13.4.3.2.1. By Application
13.4.3.2.2. By Distribution Channel
14. Middle East and Africa Molnupiravir Market Outlook
14.1. Market Size & Forecast
14.1.1. By Value & Volume
14.2. Market Share & Forecast
14.2.1. By Application
14.2.2. By Distribution Channel
14.2.3. By Country
14.3. Pricing Analysis
14.4. MEA: Country Analysis
14.4.1. South Africa Molnupiravir Market Outlook
14.4.1.1. Market Size & Forecast
14.4.1.1.1. By Value & Volume
14.4.1.2. Market Share & Forecast
14.4.1.2.1. By Application
14.4.1.2.2. By Distribution Channel
14.4.2. Saudi Arabia Molnupiravir Market Outlook
14.4.2.1. Market Size & Forecast
14.4.2.1.1. By Value & Volume
14.4.2.2. Market Share & Forecast
14.4.2.2.1. By Application
14.4.2.2.2. By Distribution Channel
14.4.3. UAE Molnupiravir Market Outlook
14.4.3.1. Market Size & Forecast
14.4.3.1.1. By Value & Volume
14.4.3.2. Market Share & Forecast
14.4.3.2.1. By Application
14.4.3.2.2. By Distribution Channel
14.4.4. Kenya Molnupiravir Market Outlook
14.4.4.1. Market Size & Forecast
14.4.4.1.1. By Value & Volume
14.4.4.2. Market Share & Forecast
14.4.4.2.1. By Application
14.4.4.2.2. By Distribution Channel
15. Market Dynamics
15.1. Drivers
15.2. Challenges
16. Market Trends & Developments
17. Competitive Landscape
17.1. Company Profiles
17.1.1. Company Details
17.1.2. Financials (As reported)
17.1.3. Key Market Focus and Geographical Presence
17.1.4. Pricing of Target Products
17.1.5. Market positioning
17.2. Merck Sharp & Dohme Corp.
17.3. Everest Organics Limited
17.4. Optimus Drugs Pvt Ltd.
17.5. Dr. Reddy?s Laboratories Ltd
17.6. Cipla Limited
17.7. Mylan N.V.
17.8. Emcure Pharmaceuticals Ltd.
17.9. Sun Pharmaceutical Industries Limited
17.10. Hetero Drugs Ltd.
17.11. Torrent Pharmaceuticals Ltd.
18. Strategic Recommendations